4 min read
Catching Plaque Early Guides Personalized Treatment and Tracking of Heart Disease
Half of patients who have a heart attack don't show symptoms prior to their event. A new standard of precision care...
Connect With Us
Artificial Intelligence & Machine Learning Hands-On WorkshopJoin us by registering here |
||
10:00 AM - 10:30 AM PST | From Dark to Bright: Leveraging Coronary CT Angiography Findings to Improve Diagnosis, Risk Stratification, Treatment Decision Making and Longitudinal Disease Tracking | James Min, MD, MSCCT |
10:30 AM - 12:30 AM PST | Sponsored workshop: AI-QCT Coronary Analysis Workshop | James Min, MD, MSCCT Jay Earls, MD, FSCCT |
Scientific Sessions and ExhibitsVisit Cleerly at booth 103 |
![]() |
CONFIRM2 Investigators Meeting & ReceptionBy invitation only |
Learn more about Cleerly's AI-enabled technology that identifies the presence, type, and amount of heart disease which improves understanding of heart attack risk, and empowers clinicians to personalize treatment for better outcomes.
If you missed our recent SCCT webinar, watch on-demand to learn how to use these stages and thresholds, which are based on evidence from coronary angiography stenosis and fractional flow reserve (FFR) data, to determine precision medical therapy based upon an individual's atherosclerotic phenotype.
Oct 18, 2022 by Cleerly
Half of patients who have a heart attack don't show symptoms prior to their event. A new standard of precision care...
Jun 8, 2022 by Cleerly
Half of patients who have a heart attack don't show symptoms prior to their event. A new standard of precision care,...
May 19, 2022 by Cleerly
For the last 50 years, cardiology care has focused on treating symptoms of heart disease, rather than its root cause -...